Press Release

Visiontree Announces Distribution Agreement with SAH Global in the EU and Middle East

Visiontree, a leader in cloud-based, patient reported outcomes, patient engagement and multi-center research/registry solutions is pleased to announce its distribution agreement with SAH Global, an internationally recognized leader in providing cutting-edge cancer treatment solutions in the Middle East and Europe. With the growing adoption and use of the Visiontree Optimal Care (VTOC) platform on a global level, this partnership with SAH Global provides an end-to-end solution for treatment facilities and the hospital enterprise, which keeps the patient at the center of outcomes and population health reporting.

The VTOC v5.0 platform is implemented at over 600 sites, including 8 of the top 10 U.S. News & World Report hospitals. It is used globally in over 12 countries with over 2.5 million patient users. VTOC. VTOC includes a library of over 200 electronic patient reported outcomes measures (ePROMs) assessments with template/timepoint manager across most medical conditions, secure two-way messaging with form alerts, as well as interoperability (via HL7 and Web service interfaces) with most hospital information systems and a suite of Web service APIs to deliver patient-centered outcomes and data collection solutions in any clinical or research environment.

SAH Global is a pioneer in Proton Therapy across the Middle East and is leading the charge in bringing a network of Proton Therapy centers in Europe and the Middle East. SAH Global is also a leading distributor of software and equipment used in the treatment of cancer in Europe and the Middle East and represents a wide range of respected international suppliers. The dedicated sales and support team at SAH Global are highly experienced in the field of cancer treatment technology solutions including proton therapy. Adding VTOC to its product suite provides SAH Global customers the ability to collect and report patient and clinician outcomes data, including dosimetric data for longitudinal outcomes on a patient and aggregate level for clinical, research and registry purposes, as well as market leading cancer survivorship programs.

"It is important for us to provide innovative and valuable solutions to our customers, and deliver a comprehensive approach to patient-centered care. Visiontree complements our vision of a comprehensive ecosystem to improve patient care in the region. The combination of SAH Global products and the VTOC platform means users will have the ability to connect disparate clinical systems and multiple centers to collect and report patient outcomes information at any time and from virtually anywhere."

Feroz Agad
Chairman of SAH Global

"By starting at the point of initial patient intake with electronic patient reported forms, the VTOC platform helps sites deliver a completely paperless workflow and capture critical data points for quality healthcare decisions and operational efficiency. Disbribution of the VTOC platform by SAH Global throughout the GCC, MENA and Europe will allow physicians and staff real-time access and reporting of relevant data and alerts in their clinic and mobile environment, as well as provide the opportunity for global benchmarking and population health data management."

Martin Pellinat
CEO & Founder of Visiontree Software, Inc.

With over a decade in clinical use, VTOC has documented improvements in patient care and the clinical workflow, including up to 20% reduction in non-urgent phone calls, up to 30% improvement in missed appointments, over 30% increased patient satisfaction, and over 40% improved compliance for capturing longitudinal ePROMs. VTOC helps providers deliver risk-adjusted outcomes data to optimize quality and efficiency in on-going patient care both at an individual patient and aggregate level.

The agreement between Visiontree and SAH Global opens the possibility for thought leaders worldwide to use the VTOC platform to share best practice templates for patient and clinician outcome reporting and promote quality and value-based healthcare standards.

About SAH Global

SAH Global's vision is committed to the introduction of Proton Therapy as one of the primary solutions for cancer treatment in the Middle East and around the World. SAH Global believes in building a strong sustainable society, and leverages the success of its global ventures to make long-term contributions to the community, promote the growth of their employees and help create a greener environment.

For more information visit: or email us at:

About Visiontree

Visiontree Software, Inc., a Brainlab company, is a leader in cloud-based, patient-centered health electronic medical records, communication and population health data management systems. The Visiontree Optimal Care (VTOC) outcomes platform is MACRA compliant as a modular EHR and implemented at over 600 sites with 2.5M+ patient records in 15+ languages.

The VTOC platform is used for multi-center research, registries and population health initiatives across multiple domains. Visiontree's customer base consists of leading academic and community centers, research organizations and medical societies globally including 17 of the top 20 U.S. News and World Report hospitals.

Improve quality, safety and research

Learn more about how we can help